Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA

Journal of Clinical Virology

Volumn 32, Issue 4, 2005, Pages 278-285

  Perrons, Chris ^a   Jelley, Rosanne ^b   Kleter, Bernhard ^c   Quint, Wim ^c   Brink, Nicola ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Delft Diagnostic Laboratory   (Netherlands)

Author keywords

Cervical dysplasia; Genotyping; HPV; Persistent infections

Indexed keywords

VIRUS DNA;

ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR PROBE; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 15244350286     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.08.009     Document Type: Article

References (30)

1. H.M. Bauer, Y. Ting, C.E. Greer, J.C. Chambers, C.J. Tashiro, and J. Chimera Genital human papillomavirus infection in female university students as determined by a PCR-based method JAMA 265 4 1991 472 477
2. R.D. Burk, P. Kelly, J. Feldman, J. Bromberg, S.H. Vermund, and J.A. DeHovitz Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors Sex Transm. Dis. 23 4 1996 333 341
3. X. Castellsague, C. Menendez, M.P. Loscertales, J.R. Kornegay, S.F. dos, and F.X. Gomez-Olive Human papillomavirus genotypes in rural Mozambique Lancet 358 9291 2001 1429 1430
4. P.E. Castle, M. Schiffman, R.D. Burk, S. Wacholder, A. Hildesheim, and R. Herrero Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types Cancer Epidemiol. Biomarkers Prev. 11 11 2002 1394 1399
5. S. Cavuslu, C. Mant, W.G. Starkey, J.M. Bible, C. Biswas, and B. Kell Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA J. Med. Virol. 49 4 1996 319 324
6. C. Clavel, M. Masure, I. Putaud, K. Thomas, J.P. Bory, and R. Gabriel Hybrid capture II, a new sensitive test for human papillomavirus detection Comparison with hybrid capture I and PCR results in cervical lesions J. Clin. Pathol. 51 10 1998 737 740
7. I.D. Duncan Guidelines for clinical practice and programme management 2nd ed. 1997 National Health Service Cervical Screening Program Publications
8. K. Elfgren, M. Kalantari, B. Moberger, B. Hagmar, and J. Dillner A population-based five-year follow-up study of cervical human papillomavirus infection Am. J. Obstet. Gynecol. 183 3 2000 561 567
9. M. Evander, K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, and E. Rylander Human papillomavirus infection is transient in young women: a population-based cohort study J. Infect. Dis. 171 4 1995 1026 1030
10. S.A. Hinchliffe, D. van Velzen, H. Korporaal, P.L. Kok, and M.E. Boon Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology Br. J. Cancer 72 4 1995 943 945
11. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N. Engl. J. Med. 338 7 1998 423 428
12. M. Howard, J. Sellors, and J. Kaczorowski Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia Obstet. Gynecol. 100 5 Pt 1 2002 972 980
13. A.M. Josefsson, P.K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, and P.K. Andersen Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study Lancet 355 9222 2000 2189 2193
14. S.K. Kjaer, A.J. van den Brule, G. Paull, E.I. Svare, M.E. Sherman, and B.L. Thomsen Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study BMJ 325 7364 2002 572 576
15. B. Kleter, L.J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, and J. ter Schegget Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus J. Clin. Microbiol. 37 8 1999 2508 2517
16. B. Kleter, L.J. van Doorn, J. ter Schegget, L. Schrauwen, K. van Krimpen, and M. Burger Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses Am. J. Pathol. 153 6 1998 1731 1739
17. A.T. Lorincz, P.E. Castle, M.E. Sherman, D.R. Scott, A.G. Glass, and S. Wacholder Viral load of human papillomavirus and risk of CIN3 or cervical cancer Lancet 360 9328 2002 228 229
18. C.J. Meijer, P.J. Snijders, and A.J. van den Brule Screening for cervical cancer: should we test for infection with high-risk HPV? CMAJ 163 5 2000 535 538
19. P.W. Melkert, E. Hopman, A.J. van den Brule, E.K. Risse, P.J. van Diest, and O.P. Bleker Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent Int. J. Cancer 53 6 1993 919 923
20. Perrons C, Jelley R, Kleter B, Quint W, Brink N. Sequential HPV DNA detection and genotyping in an inner London colposcopy clinic. In: Proceedings of the 20th International Papillomavirus Conference;2002: P136 (abstract).
21. M. Poljak, I.J. Marin, K. Seme, and A. Vince Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail J. Clin. Virol. 25 Suppl. 3 2002 S89 S97
22. A.J. Remmink, J.M. Walboomers, T.J. Helmerhorst, F.J. Voorhorst, L. Rozendaal, and E.K. Risse The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months Int. J. Cancer 61 3 1995 306 311
23. M.C. Rousseau, L.L. Villa, M.C. Costa, M. Abrahamowicz, T.E. Rohan, and E. Franco Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities Sex Transm. Dis. 30 7 2003 581 587
24. L. Rozendaal, J.M. Walboomers, J.C. van der Linden, F.J. Voorhorst, P. Kenemans, and T.J. Helmerhorst PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears Int. J. Cancer 68 6 1996 766 769
25. N.F. Schlecht, S. Kulaga, J. Robitaille, S. Ferreira, M. Santos, and R.A. Miyamura Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 24 2001 3106 3114
26. J.W. Sellors, J.B. Mahony, J. Kaczorowski, A. Lytwyn, H. Bangura, and S. Chong Prevalence and predictors of human papillomavirus infection in women in Ontario Canada. Survey of HPV in Ontario Women (SHOW) Group CMAJ 163 5 2000 503 508
27. Y. van der Graaf, A. Molijn, H. Doornewaard, W. Quint, L.J. van Doorn, and T.J. van den Human papillomavirus and the long-term risk of cervical neoplasia Am. J. Epidemiol. 156 2 2002 158 164
28. M. van Duin, P.J. Snijders, H.F. Schrijnemakers, F.J. Voorhorst, L. Rozendaal, and M.A. Nobbenhuis Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance Int. J. Cancer 98 4 2002 590 595
29. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1 1999 12 19
30. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836